Patents by Inventor Lucille Bitensky

Lucille Bitensky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6369107
    Abstract: Effective synergistic amounts of (i) a compound that acts on the chondrocytes such as a fenamic acid derivative and (ii) a compound that reduces the water content of the chondrocyte matrix such as one based on a sugar nucleus with bulky substituents, as a combined preparation, are useful for simultaneous, separate or sequential use in the treatment of osteoarthritis.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: April 9, 2002
    Assignee: KS Biomedix Ltd.
    Inventors: Joseph Chayen, Lucille Bitensky
  • Patent number: 6034122
    Abstract: Diclofenac sodium and tribenoside, or more generally (i) a compound that acts on the chondrocytes and (ii) a compound that reduces the water content of the chondrocyte matrix, are useful in the treatment of osteoarthritis.
    Type: Grant
    Filed: January 5, 1998
    Date of Patent: March 7, 2000
    Assignee: KS Biomedix Ltd.
    Inventors: Joseph Chayen, Lucille Bitensky, deceased, by Martin Roy Kagan, executor
  • Patent number: 5763479
    Abstract: A redox, hydrogen-acceptor compound, having utility in treating inflammation, is a 1,4-dioxonaphthalene or 1,4-dilminon aphthalene having either a 2,3-double bond, in which cast there are 2 and 3-substituents, or a 2,3-single bond. Examples of such compounds are menadione epoxide and water-soluble derivatives or menadione such as menadione bisulphite.
    Type: Grant
    Filed: July 12, 1993
    Date of Patent: June 9, 1998
    Assignee: KS Biomedix Ltd.
    Inventors: Joseph Chayen, Lucille Bitensky, George T. B. Frost